Squamous cell carcinoma of the hypopharynx

Search with Google Search with Bing
Information
Disease name
Squamous cell carcinoma of the hypopharynx
Disease ID
Description
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
TP53 17 7,668,421 7,687,490 10
FBXO11 2 47,806,920 47,906,498 4
JAK3 19 17,824,782 17,847,982 4
MSH6 2 47,783,145 47,806,953 4
FMN2 1 240,091,883 240,475,187 4
ROS1 6 117,288,300 117,425,855 4
PSIP1 9 15,464,066 15,510,995 4
INSR 19 7,112,265 7,294,414 4
PMS1 2 189,784,450 189,877,629 2
PMS2 7 5,970,957 6,009,122 2
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03370276 Active, not recruiting Phase 1/Phase 2 Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma December 20, 2017 August 2024
NCT00508664 Completed Phase 2 Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) July 2007 February 2015
NCT01314755 Completed N/A A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer November 2003 July 2008
NCT05608369 Not yet recruiting Phase 2 Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC June 1, 2024 February 1, 2026
NCT05752149 Not yet recruiting Phase 2 Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial June 2024 November 2025
NCT06380686 Not yet recruiting Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome May 2024 May 2030
NCT06030440 Recruiting Phase 2/Phase 3 De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck January 26, 2024 September 2033